QT
PGNX

Quantbot Technologies’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quantbot Technologies’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,412
Closed -$42K – 1728
2019
Q3 		$42K Buy
+8,412
New +$42K ﹤0.01% 1014
2017
Q2 		– Sell
-18,610
Closed -$175K – 1497
2017
Q1 		$175K Buy
+18,610
New +$186K 0.02% 647
2015
Q4 		– Sell
-4,885
Closed -$27K – 1498
2015
Q3 		$27K Buy
4,885
+2,283
+88% +$17.5K ﹤0.01% 1000
2015
Q2 		$19K Buy
+2,602
New +$15.7K ﹤0.01% 942
2015
Q1 		– Sell
-2,202
Closed -$16K – 1463
2014
Q4 		$16K Buy
+2,202
New +$13.2K 0.01% 975

Other funds holding PGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantbot Technologies's PGNX Position: Q4 2019 in Review

Quantbot Technologies sold out of Progenics Pharmaceuticals Inc (PGNX) in Q4 2019, closing a stake of 8,412 shares — an estimated $42K sold.

Quantbot Technologies first reported a position in PGNX in Q4 2014 and held it in 5 quarters. The position peaked at $175K in Q1 2017. 128 funds tracked by Wall St. Rank hold PGNX as of Q4 2019.

  • Quantbot Technologies reported no remaining Progenics Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
  • Quantbot Technologies sold 8,412 Progenics Pharmaceuticals Inc shares in Q4 2019, an estimated $42K.
  • Quantbot Technologies first reported a position in Progenics Pharmaceuticals Inc in Q4 2014 and held it in 5 quarters.
  • Quantbot Technologies's Progenics Pharmaceuticals Inc position peaked at $175K in Q1 2017.
  • 128 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2019.

Based on Quantbot Technologies's 13F filing for Q4 2019, filed 10 Feb 2020.